{
  "disease_name": "MELAS",
  "orpha_code": "550",
  "drugs": [
    {
      "name": "Vatiquinone",
      "substance_url": "/en/drug/substance/285822?name=550&mode=orpha&region=&status=all",
      "substance_id": "285822",
      "regulatory_url": "/en/drug/regulatory/627329?name=550&mode=orpha&region=",
      "regulatory_id": "627329",
      "orpha_substance_code": "ORPHA:550",
      "details": [
        "Vatiquinone(Medicinal product                        - 24/02/2022)Disease(s) concernedORPHA:550 MELAS",
        "Vatiquinone(Medicinal product                        - 24/02/2022)",
        "(Medicinal product                        - 24/02/2022)",
        "Disease(s) concernedORPHA:550 MELAS",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/285822?name=550&mode=orpha&region=&status=all",
          "text": "Vatiquinone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/550",
          "text": "ORPHA:550 MELAS",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627329?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione",
      "substance_url": "/en/drug/substance/500664?name=550&mode=orpha&region=&status=all",
      "substance_id": "500664",
      "regulatory_url": "/en/drug/regulatory/500665?name=550&mode=orpha&region=",
      "regulatory_id": "500665",
      "orpha_substance_code": "ORPHA:550",
      "details": [
        "2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione(Medicinal product                        - 12/12/2017)Disease(s) concernedORPHA:550 MELAS",
        "2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione(Medicinal product                        - 12/12/2017)",
        "(Medicinal product                        - 12/12/2017)",
        "Disease(s) concernedORPHA:550 MELAS",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/500664?name=550&mode=orpha&region=&status=all",
          "text": "2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/550",
          "text": "ORPHA:550 MELAS",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/500665?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride",
      "substance_url": "/en/drug/substance/410354?name=550&mode=orpha&region=&status=all",
      "substance_id": "410354",
      "regulatory_url": "/en/drug/regulatory/444904?name=550&mode=orpha&region=",
      "regulatory_id": "444904",
      "orpha_substance_code": "ORPHA:550",
      "details": [
        "(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride(Medicinal product                        - 10/08/2015)Disease(s) concernedORPHA:550 MELAS",
        "(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride(Medicinal product                        - 10/08/2015)",
        "(Medicinal product                        - 10/08/2015)",
        "Disease(s) concernedORPHA:550 MELAS",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/410354?name=550&mode=orpha&region=&status=all",
          "text": "(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/550",
          "text": "ORPHA:550 MELAS",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/444904?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate",
      "substance_url": "/en/drug/substance/604812?name=550&mode=orpha&region=&status=all",
      "substance_id": "604812",
      "regulatory_url": "/en/drug/regulatory/604813?name=550&mode=orpha&region=",
      "regulatory_id": "604813",
      "orpha_substance_code": "ORPHA:550",
      "details": [
        "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate(Medicinal product                        - 21/08/2020)Disease(s) concernedORPHA:550 MELAS",
        "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate(Medicinal product                        - 21/08/2020)",
        "(Medicinal product                        - 21/08/2020)",
        "Disease(s) concernedORPHA:550 MELAS",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604812?name=550&mode=orpha&region=&status=all",
          "text": "Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/550",
          "text": "ORPHA:550 MELAS",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604813?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=550&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=550&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=550&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide",
      "substance_url": "/en/drug/substance/687120?name=550&mode=orpha&region=&status=all",
      "substance_id": "687120",
      "regulatory_url": "/en/drug/regulatory/687279?name=550&mode=orpha&region=",
      "regulatory_id": "687279",
      "orpha_substance_code": "ORPHA:206966",
      "details": [
        "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide(Medicinal product                        - 26/08/2024)Disease(s) concernedORPHA:206966 Mitochondrial myopathy",
        "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide(Medicinal product                        - 26/08/2024)",
        "(Medicinal product                        - 26/08/2024)",
        "Disease(s) concernedORPHA:206966 Mitochondrial myopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/687120?name=550&mode=orpha&region=&status=all",
          "text": "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/206966",
          "text": "ORPHA:206966 Mitochondrial myopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687279?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate",
      "substance_url": "/en/drug/substance/646586?name=550&mode=orpha&region=&status=all",
      "substance_id": "646586",
      "regulatory_url": "/en/drug/regulatory/646683?name=550&mode=orpha&region=",
      "regulatory_id": "646683",
      "orpha_substance_code": "ORPHA:68380",
      "details": [
        "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate(Medicinal product                        - 14/04/2023)Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate(Medicinal product                        - 14/04/2023)",
        "(Medicinal product                        - 14/04/2023)",
        "Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/646586?name=550&mode=orpha&region=&status=all",
          "text": "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/68380",
          "text": "ORPHA:68380 Mitochondrial disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/646683?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Zagociguat",
      "substance_url": "/en/drug/substance/644348?name=550&mode=orpha&region=&status=all",
      "substance_id": "644348",
      "regulatory_url": "/en/drug/regulatory/644353?name=550&mode=orpha&region=",
      "regulatory_id": "644353",
      "orpha_substance_code": "ORPHA:68380",
      "details": [
        "Zagociguat(Medicinal product                        - 23/03/2023)Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "Zagociguat(Medicinal product                        - 23/03/2023)",
        "(Medicinal product                        - 23/03/2023)",
        "Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/644348?name=550&mode=orpha&region=&status=all",
          "text": "Zagociguat",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/68380",
          "text": "ORPHA:68380 Mitochondrial disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/644353?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=550&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=550&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=550&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Vatiquinone",
      "substance_url": "/en/drug/substance/285822?name=550&mode=orpha&region=&status=all",
      "substance_id": "285822",
      "regulatory_url": "/en/drug/regulatory/299940?name=550&mode=orpha&region=",
      "regulatory_id": "299940",
      "orpha_substance_code": "ORPHA:254827",
      "details": [
        "Vatiquinone(Medicinal product                        - 21/12/2010)Disease(s) concernedORPHA:223713 Mitochondrial oxidative phosphorylation disorderORPHA:254827 Mitochondrial membrane transport disorder",
        "Vatiquinone(Medicinal product                        - 21/12/2010)",
        "(Medicinal product                        - 21/12/2010)",
        "Disease(s) concernedORPHA:223713 Mitochondrial oxidative phosphorylation disorderORPHA:254827 Mitochondrial membrane transport disorder",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/285822?name=550&mode=orpha&region=&status=all",
          "text": "Vatiquinone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/223713",
          "text": "ORPHA:223713 Mitochondrial oxidative phosphorylation disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/254827",
          "text": "ORPHA:254827 Mitochondrial membrane transport disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/299940?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:254827 Mitochondrial membrane transport disorder\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=550&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=550&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=550&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=550&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:03:01.826566",
  "run_number": 1,
  "total_drugs_found": 11,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=MELAS&orphaCode=550&name=550&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "MELAS",
    "orphaCode": "550",
    "name": "550",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}